| Literature DB >> 24134520 |
Ling Zhao, Jixin Liu, Xilin Dong, Yulin Peng, Kai Yuan, Fumei Wu, Jinbo Sun, Qiyong Gong, Wei Qin1, Fanrong Liang.
Abstract
BACKGROUND: Advanced neuroimaging approaches have been employed to prove that migraine was a central nervous system disorder. This study aims to examine resting-state abnormalities in migraine without aura (MWoA) patients stratified by disease duration, and to explore the neuroimaging markers for reflecting the disease duration.Entities:
Mesh:
Year: 2013 PMID: 24134520 PMCID: PMC3853130 DOI: 10.1186/1129-2377-14-85
Source DB: PubMed Journal: J Headache Pain ISSN: 1129-2369 Impact factor: 7.277
Baseline and demographics for MWoA patients and healthy subjects
| Age (years) mean (SD) | 30.5(10.8) | 28.4(8.9) | 0.4569 |
| Gender (male/female) | 12/28 | 5/15 | 0.4658 |
| Education (years) | 12.6(4.7) | 14.2(6.4) | 0.2764 |
| Mean disease duration in years (SD) | 10.15(7.01) | NA |
Notes: SD, Standard deviation.
Baseline and demographics for MWoA patients
| Age (years) mean (SD) | 27.12 (8.18) | 37.52 (12.2) | 0.0009 |
| Gender (male/female) | 5/15 | 7/13 | 0.7311 |
| Education (years) | 13.2 (6.03) | 13.8 (5.06) | 0.7352 |
| Family history (Y/N) | 6/14 | 8/12 | 0.3705 |
| Disease duration in years (SD) | 4.05 (1.64) | 16.25 (1.47) | 0.0000 |
| Affect frequency per month* (SD) | 4.5 (3.5) | 5.38 (5.8) | 0.5647 |
| VAS score* | 5.37 (1.34) | 5.0 (1.8) | 0.4654 |
Notes: SD, Standard deviation; VAS, Visual Analogue Scale; Y, yes; N, no.
*measured for the 4 weeks before enrolment.
Figure 1Differences between MWoA patients and healthy subjects in ReHo values. a. MWoA patients with ST disease duration; b. MWoA patients with LT disease duration; p < 0.01, FDR corrected; Warm colors indicate ReHo increases in MWoA patients; cool colors indicate ReHo decreases in MWoA patients.
Figure 2The correlation of average ReHo values of the overlapped brain dysfunction in LT HC and LT ST with the disease duration. Warm colors indicate ReHo increases in MWoA patients; cool colors indicate ReHo decreases in MWoA patients; ACC, anterior cingulate cortex; THAL, thalamus; TP, temporal pole; PCC, posterior cingulate cortex; SOG, superior occipital gyrus; LT, MWoA patients with long-term disease duration; ST, MWoA patients with short-term disease duration; HC, healthy controls.